Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 4455-4466

  Dartt, Darlene A ^a,b   Hodges, Robin R ^a,b   Li, Dayu ^a,b   Shatos, Marie A ^a,b   Lashkari, Kameran ^a,b   Serhan, Charles N ^c  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CALCIUM ION; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OMEGA 3 FATTY ACID; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN D2; RESOLVIN D1; RESOLVIN E1; UNCLASSIFIED DRUG; VERLUKAST;

ADULT; AGED; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CELL SECRETION; CONJUNCTIVAL GOBLET CELL; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GOBLET CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; MALE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; RAT;

AGED; ANIMALS; CELLS, CULTURED; CONJUNCTIVA; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; GOBLET CELLS; HUMANS; INFLAMMATION MEDIATORS; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; MALE; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LEUKOTRIENE;

EID: 79955048969     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000833     Document Type: Article

References (48)

1. Rogers, D. F. 2003. The airway goblet cell. Int. J. Biochem. Cell Biol. 35: 1-6. (Pubitemid 35449167)
2. Kim, D. H., H. S. Chu, J. Y. Lee, S. J. Hwang, S. H. Lee, and H. M. Lee. 2004. Up-regulation of MUC5AC and MUC5B mucin genes in chronic rhinosinusitis. Arch. Otolaryngol. Head Neck Surg. 130: 747-752. (Pubitemid 38725050)
3. Gersemann, M., S. Becker, I. Kübler, M. Koslowski, G. Wang, K. R. Herrlinger, J. Griger, P. Fritz, K. Fellermann, M. Schwab, et al. 2009. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. Differentiation 77: 84-94.
4. Lemp, M., C. Baudoiin, J. Baum, M. Dogru, G. Foulks, S. Kinoshita, P. Laibson, J. McCulley, J. Murube, S. C. Pflugfelder, et al. 2007. The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf. 5: 75-92. (Pubitemid 351902651)
5. Dartt, D. A. 2004. Control of mucin production by ocular surface epithelial cells. Exp. Eye Res. 78: 173-185. (Pubitemid 38077225)
6. Ríos, J. D., K. Forde, Y. Diebold, J. Lightman, J. D. Zieske, and D. A. Dartt. 2000. Development of conjunctival goblet cells and their neuroreceptor subtype expression. Invest. Ophthalmol. Vis. Sci. 41: 2127-2137. (Pubitemid 30450984)
7. Ríos, J. D., D. Zoukhri, I. M. Rawe, R. R. Hodges, J. D. Zieske, and D. A. Dartt. 1999. Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion. Invest. Ophthalmol. Vis. Sci. 40: 1102-1111. (Pubitemid 29211447)
8. Dartt, D. A., J. D. Rios, H. Kanno, I. M. Rawe, J. D. Zieske, N. Ralda, R. R. Hodges, and D. Zoukhri. 2000. Regulation of conjunctival goblet cell secretion by Ca(2+)and protein kinase C. [Published erratum appears in 2001 Exp. Eye Res. 72 :357.] Exp. Eye Res. 71: 619-628. (Pubitemid 32002248)
9. Kanno, H., Y. Horikawa, R. R. Hodges, D. Zoukhri, M. A. Shatos, J. D. Rios, and D. A. Dartt. 2003. Cholinergic agonists transactivate EGFR and stimulate MAPK to induce goblet cell secretion. Am. J. Physiol. Cell Physiol. 284: C988-C998. (Pubitemid 36336955)
10. Samuelsson, B., S. E. Dahlén, J. A. Lindgren, C. A. Rouzer, and C. N. Serhan. 1987. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 237: 1171-1176. (Pubitemid 17131222)
11. Serhan, C. N., N. Chiang, and T. E. Van Dyke. 2008. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8: 349-361. (Pubitemid 351595216)
12. Serhan, C. N. 2007. Resolution phase of inflammation: Novel endogenous antiinflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25: 101-137. (Pubitemid 46697904)
13. Serhan, C. N., C. B. Clish, J. Brannon, S. P. Colgan, N. Chiang, and K. Gronert. 2000. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192: 1197-1204.
14. Serhan, C. N. 2008. Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators. Prostaglandins Leukot. Essent. Fatty Acids 79: 157-163.
15. Haworth, O., M. Cernadas, R. Yang, C. N. Serhan, and B. D. Levy. 2008. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 9: 873-879.
16. Serhan, C. N., S. Hong, K. Gronert, S. P. Colgan, P. R. Devchand, G. Mirick, and R. L. Moussignac. 2002. Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196: 1025-1037. (Pubitemid 35231761)
17. Kasuga, K., R. Yang, T. F. Porter, N. Agrawal, N. A. Petasis, D. Irimia, M. Toner, and C. N. Serhan. 2008. Rapid appearance of resolvin precursors in inflammatory exudates: Novel mechanisms in resolution. J. Immunol. 181: 8677-8687.
18. Duffield, J. S., S. Hong, V. S. Vaidya, Y. Lu, G. Fredman, C. N. Serhan, and J. V. Bonventre. 2006. Resolvin D series and protectin D1 mitigate acute kidney injury. J. Immunol. 177: 5902-5911. (Pubitemid 44628803)
19. Connor, K. M., J. P. SanGiovanni, C. Lofqvist, C. M. Aderman, J. Chen, A. Higuchi, S. Hong, E. A. Pravda, S. Majchrzak, D. Carper, et al. 2007. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 13: 868-873. (Pubitemid 47038185)
20. Aguirre, S. A., W. Huang, G. Prasanna, and B. Jessen. 2009. Corneal neovascularization and ocular irritancy responses in dogs following topical ocular administration of an EP4-prostaglandin E2 agonist. Toxicol. Pathol. 37: 911-920.
21. Shatos, M. A., J. Gu, R. R. Hodges, K. Lashkari, and D. A. Dartt. 2008. ERK/ p44p42 mitogen-activated protein kinase mediates EGF-stimulated proliferation of conjunctival goblet cells in culture. Invest. Ophthalmol. Vis. Sci. 49: 3351-3359.
22. Shatos, M. A., R. R. Hodges, J. A. Bair, K. Lashkari, and D. A. Dartt. 2009. Stimulatory role of PKCalpha in extracellular regulated kinase 1/2 pathway in conjunctival goblet cell proliferation. Invest. Ophthalmol. Vis. Sci. 50: 1619-1625.
23. Shatos, M. A., J. D. Ríos, Y. Horikawa, R. R. Hodges, E. L. Chang, C. R. Bernardino, P. A. Rubin, and D. A. Dartt. 2003. Isolation and characterization of cultured human conjunctival goblet cells. Invest. Ophthalmol. Vis. Sci. 44: 2477-2486. (Pubitemid 36618404)
24. Arita, M., F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N. A. Petasis, and C. N. Serhan. 2005. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201: 713-722. (Pubitemid 40395117)
25. Sun, Y. P., S. F. Oh, J. Uddin, R. Yang, K. Gotlinger, E. Campbell, S. P. Colgan, N. A. Petasis, and C. N. Serhan. 2007. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282: 9323-9334. (Pubitemid 47104612)
26. Ríos, J. D., E. Ghinelli, J. Gu, R. R. Hodges, and D. A. Dartt. 2007. Role of neurotrophins and neurotrophin receptors in rat conjunctival goblet cell secretion and proliferation. Invest. Ophthalmol. Vis. Sci. 48: 1543-1551. (Pubitemid 351261337)
27. Labat, C., J. L. Ortiz, X. Norel, I. Gorenne, J. Verley, T. S. Abram, N. J. Cuthbert, S. R. Tudhope, P. Norman, P. Gardiner, et al. 1992. A second cysteinyl leukotriene receptor in human lung. J. Pharmacol. Exp. Ther. 263: 800-805.
28. Abramovitz, M., E. Wong, M. E. Cox, C. D. Richardson, C. Li, and P. J. Vickers. 1993. 5-Lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur. J. Biochem. 215: 105-111. (Pubitemid 23211131)
29. Krishnamoorthy, S., A. Recchiuti, N. Chiang, S. Yacoubian, C. H. Lee, R. Yang, N. A. Petasis, and C. N. Serhan. 2010. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci U S A 107: 1660-1665.
30. Ohira, T., M. Arita, K. Omori, A. Recchiuti, T. E. Van Dyke, and C. N. Serhan. 2010. Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J. Biol. Chem. 285: 3451-3461.
31. Wittamer, V., F. Grégoire, P. Robberecht, G. Vassart, D. Communi, and M. Parmentier. 2004. The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J. Biol. Chem. 279: 9956-9962. (Pubitemid 38372597)
32. Galatowicz, G., Y. Ajayi, M. E. Stern, and V. L. Calder. 2007. Ocular antiallergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo. Clin. Exp. Allergy 37: 1648-1656. (Pubitemid 47609843)
33. Schultz, B. L. 2006. Pharmacology of ocular allergy. Curr. Opin. Allergy Clin. Immunol. 6: 383-389. (Pubitemid 44368247)
34. Lam, H., L. Bleiden, C. S. de Paiva, W. Farley, M. E. Stern, and S. C. Pflugfelder. 2009. Tear cytokine profiles in dysfunctional tear syndrome. Am. J. Ophthalmol. 147: 198-205e1.
35. Smith, J., J. Albeitz, C. Begley, B. Caffery, K. Nichols, D. A. Schaumberg, and O. Schein. 2007. The epidemiology of dry eye disease: Report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf. 5: 93-107. (Pubitemid 351902652)
36. Ono, S. J., and M. B. Abelson. 2005. Allergic conjunctivitis: Update on pathophysiology and prospects for future treatment. J. Allergy Clin. Immunol. 115: 118-122. (Pubitemid 40075430)
37. Woodward, D. F., C. S. Spada, A. L. Nieves, S. B. Hawley, and L. S. Williams. 1989. Platelet-activating factor causes goblet cell depletion in the conjunctiva. Eur. J. Pharmacol. 168: 23-30. (Pubitemid 19217156)
38. Horikawa, Y., M. A. Shatos, R. R. Hodges, D. Zoukhri, J. D. Rios, E. L. Chang, C. R. Bernardino, P. A. Rubin, and D. A. Dartt. 2003. Activation of mitogenactivated protein kinase by cholinergic agonists and EGF in human compared with rat cultured conjunctival goblet cells. Invest. Ophthalmol. Vis. Sci. 44: 2535-2544. (Pubitemid 36618412)
39. Lambiase, A., S. Bonini, G. Rasi, M. Coassin, A. Bruscolini, and S. Bonini. 2003. Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma. Arch. Ophthalmol. 121: 615-620. (Pubitemid 36554462)
40. Sousa, A. R., A. Parikh, G. Scadding, C. J. Corrigan, and T. H. Lee. 2002. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirinsensitive rhinosinusitis. N. Engl. J. Med. 347: 1493-1499. (Pubitemid 35257588)
41. Capra, V. 2004. Molecular and functional aspects of human cysteinyl leukotriene receptors. Pharmacol. Res. 50: 1-11. (Pubitemid 38479663)
42. Paruchuri, S., H. Tashimo, C. Feng, A. Maekawa, W. Xing, Y. Jiang, Y. Kanaoka, P. Conley, and J. A. Boyce. 2009. Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J. Exp. Med. 206: 2543-2555.
43. Aoki, H., T. Hisada, T. Ishizuka, M. Utsugi, T. Kawata, Y. Shimizu, F. Okajima, K. Dobashi, and M. Mori. 2008. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem. Biophys. Res. Commun. 367: 509-515.
44. Nieto, N., M. I. Torres, A. Ríos, and A. Gil. 2002. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J. Nutr. 132: 11-19. (Pubitemid 34042448)
45. Jin, Y., M. Arita, Q. Zhang, D. R. Saban, S. K. Chauhan, N. Chiang, C. N. Serhan, and R. Dana. 2009. Anti-angiogenesis effect of the novel antiinflammatory and pro-resolving lipid mediators. Invest. Ophthalmol. Vis. Sci. 50: 4743-4752.
46. Herrera, B. S., T. Ohira, L. Gao, K. Omori, R. Yang, M. Zhu, M. N. Muscara, C. N. Serhan, T. E. Van Dyke, and R. Gyurko. 2008. An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption. Br. J. Pharmacol. 155: 1214-1223.
47. Arita, M., M. Yoshida, S. Hong, E. Tjonahen, J. N. Glickman, N. A. Petasis, R. S. Blumberg, and C. N. Serhan. 2005. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA 102: 7671-7676. (Pubitemid 40741029)
48. Hasturk, H., A. Kantarci, T. Ohira, M. Arita, N. Ebrahimi, N. Chiang, N. A. Petasis, B. D. Levy, C. N. Serhan, and T. E. Van Dyke. 2006. RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. FASEB J. 20: 401-403. (Pubitemid 46671185)